Lars Lind
Lars Lind publishes mostly in Cardiology and Cardiovascular Medicine, Physiology and Endocrinology, Diabetes and Metabolism, on topics such as Blood Pressure and Hypertension Studies, Cardiovascular Function and Risk Factors and Cardiovascular Health and Disease Prevention.
- World rank
- #1,249,222 of 7,710,434 ranked researchers
- Rank in Sweden
- #16,111 of 71,437
- Works
- 243
- Citations
- 5.5k
- Citations per work
- 22.4
What does Lars Lind research?
Lars Lind's work is mostly in Medicine (41%), Environmental Science (6%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else11848.7%
- Health Sciences10041.2%
- Medicine10041.2%
- Physical Sciences145.7%
- Environmental Science145.7%
- Life Sciences114.4%
- 1Cardiology and Cardiovascular Medicine22% of their works
- 2Physiology7% of their works
- 3Endocrinology, Diabetes and Metabolism6% of their works
- 4Epidemiology6% of their works
- 5Health, Toxicology and Mutagenesis6% of their works
- 6Genetics4% of their works
Research topics
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
- Cardiovascular Health and Disease Prevention
- Adipokines, Inflammation, and Metabolic Diseases
- Cardiovascular Disease and Adiposity
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet and metabolism studies
- Effects and risks of endocrine disrupting chemicals
Which keywords describe Lars Lind's research?
The keywords of their largest research topics: Cardiovascular Disease, Obesity, Cardiovascular Events, Hypertension, Inflammation, Metabolic Syndrome, Insulin Resistance and Atherosclerosis.
- Endocrine-Disrupting Chemicals
- Low-Carbohydrate Diet
- Glucose Metabolism
- Perivascular Adipose Tissue
- Adipose Tissue
- Endothelial Dysfunction
- Echocardiography
- Blood Pressure
- Atherosclerosis
- Metabolic Syndrome
- Hypertension
- Obesity
- Cardiovascular Disease
- Cardiovascular Events
- Inflammation
- Insulin Resistance
- Antihypertensive Drugs
- Chamber Quantification
- Arterial Stiffness
- Adipokines
- Epicardial Fat
- Diabetes
- Ketogenic Diet
- Bisphenol A
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Cardiovascular Disease644 topics
- Obesity644 topics
- Cardiovascular Events432 topics
- Hypertension432 topics
- Inflammation423 topics
- Metabolic Syndrome413 topics
- Insulin Resistance282 topics
- Atherosclerosis272 topics
- Antihypertensive Drugs221 topic
- Blood Pressure221 topic
- Chamber Quantification221 topic
- Echocardiography221 topic
- Arterial Stiffness211 topic
- Endothelial Dysfunction211 topic
- Adipokines151 topic
- Adipose Tissue151 topic
- Epicardial Fat141 topic
- Perivascular Adipose Tissue141 topic
- Diabetes131 topic
- Glucose Metabolism131 topic
- Ketogenic Diet131 topic
- Low-Carbohydrate Diet131 topic
- Bisphenol A121 topic
- Endocrine-Disrupting Chemicals121 topic
Where does Lars Lind work?
Lars Lind's main affiliation in the publication record is Uppsala University, Sweden.
How many publications and citations does Lars Lind have?
OpenAlex counts 243 works and 5,453 citations for Lars Lind, an h-index of 37, ranking #1,249,222 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Lars Lind
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lars Lind. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.